Bamlanivimab

Definition: Bamlanivimab is a monoclonal antibody developed by AbCellera Biologics and Eli Lilly as a treatment for COVID-19. The medication was granted an emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in November 2020, and the EUA was revoked in April 2021. Bamlanivimab is an IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2. source: Wikipedia

ID

1119336002

ID date

7 Jan 2022

Previous ID

39211011000001106

Name

Bamlanivimab